Zhende Medical Co Stock EBITDA
| 603301 Stock | 20.37 0.22 1.07% |
Zhende Medical Co fundamentals help investors to digest information that contributes to Zhende Medical's financial success or failures. It also enables traders to predict the movement of Zhende Stock. The fundamental analysis module provides a way to measure Zhende Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zhende Medical stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 1.2 B | 1.2 B |
Zhende | EBITDA |
Zhende Medical Co Company EBITDA Analysis
Zhende Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Zhende Medical EBITDA | 462.31 M |
Most of Zhende Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zhende Medical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Zhende Ebitda
Ebitda |
|
According to the company disclosure, Zhende Medical Co reported earnings before interest,tax, depreciation and amortization of 462.31 M. This is 47.31% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 470.46 M) industry. The ebitda for all China stocks is 88.14% higher than that of the company.
Zhende EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zhende Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zhende Medical could also be used in its relative valuation, which is a method of valuing Zhende Medical by comparing valuation metrics of similar companies.Zhende Medical is currently under evaluation in ebitda category among its peers.
Zhende Fundamentals
| Return On Equity | 0.0385 | ||||
| Return On Asset | 0.0156 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 5.35 B | ||||
| Shares Outstanding | 266.45 M | ||||
| Shares Owned By Insiders | 61.20 % | ||||
| Shares Owned By Institutions | 9.34 % | ||||
| Price To Book | 0.98 X | ||||
| Price To Sales | 1.35 X | ||||
| Revenue | 4.13 B | ||||
| Gross Profit | 1.74 B | ||||
| EBITDA | 462.31 M | ||||
| Net Income | 198.4 M | ||||
| Total Debt | 220.14 M | ||||
| Book Value Per Share | 20.96 X | ||||
| Cash Flow From Operations | 452.11 M | ||||
| Earnings Per Share | 0.76 X | ||||
| Target Price | 28.0 | ||||
| Number Of Employees | 6.72 K | ||||
| Beta | 0.43 | ||||
| Market Capitalization | 5.48 B | ||||
| Total Asset | 7.27 B | ||||
| Retained Earnings | 3.14 B | ||||
| Working Capital | 1.55 B | ||||
| Net Asset | 7.27 B | ||||
| Last Dividend Paid | 1.25 |
About Zhende Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zhende Medical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhende Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhende Medical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Zhende Stock
Zhende Medical financial ratios help investors to determine whether Zhende Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhende with respect to the benefits of owning Zhende Medical security.